Stay updated with breaking news from Nathanj dowden. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- With a proven track record at Entrada and across his 30-year career in the healthcare sector, Mr. Dowden is well-positioned to help continue driving. ....
HC Wainwright reissued their buy rating on shares of Entrada Therapeutics (NASDAQ:TRDA – Free Report) in a research report report published on Friday morning, Benzinga reports. The firm currently has a $25.00 price objective on the stock. Entrada Therapeutics Trading Up 3.5 % Shares of NASDAQ TRDA opened at $14.93 on Friday. The stock has […] ....
Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Free Report) COO Nathan J. Dowden sold 972 shares of Entrada Therapeutics stock in a transaction on Wednesday, September 6th. The stock was sold at an average price of $13.47, for a total transaction of $13,092.84. Following the sale, the chief operating officer now owns 48,168 shares of the […] ....
CHI Advisors LLC Takes Position in Entrada Therapeutics, Inc. (NASDAQ:TRDA) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Research Analysts Issue Forecasts for Entrada Therapeutics, Inc.'s Q3 2023 Earnings (NASDAQ:TRDA) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.